Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Raman spectroscopy could effectively guide skin cancer surgery by identifying tumor margins.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

A cancer patient's hair became permanently curly after treatment with nivolumab.

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.

Alopecia areata involves unique activation of certain immune cells.

The CTLA-4 gene polymorphism does not affect polycystic ovarian syndrome.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

MCHR2 gene duplications may be linked to alopecia areata.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

lncRNA2919 slows down rabbit hair growth by stopping cell growth and causing cell death.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Six months after COVID-19, most patients still had autoantibodies.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.